rivastigmine tartrate 3 mg
1 INDICATIONS AND USAGE Rivastigmine tartrate capsules are an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) ( 1.1 ) Mild-to-moderate dementia associated with Parkinson’s disease (PD) ( 1.2 ) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).
aurobindo pharma limited
CAPSULE ORANGE H 68
H 68 CAPSULE ORANGE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIVASTIGMINE TARTRATE capsules, USP equivalent to 1.5 mg, 3 mg, 4.5 mg, or 6 mg of rivastigmine base are available as follows:
RIVASTIGMINE TARTRATE capsules USP, 1.5 mg are yellow cap and yellow body colored size ‘2’ capsules imprinted in black ink with ‘H’ on cap and ‘67’ on body, containing white to off-white granular powder. Bottles of 60 NDC 65862-648-60 Bottles of 500 NDC 65862-648-05 10 x 10 Unit-dose capsules NDC 65862-648-78
RIVASTIGMINE TARTRATE capsules USP, 3 mg are orange cap and orange body colored size ‘2’ capsules imprinted in black ink with ‘H’ on cap and ‘68’ on body, containing white to off-white granular powder. Bottles of 60 NDC 65862-649-60 Bottles of 500 NDC 65862-649-05 10 x 10 Unit-dose capsules NDC 65862-649-78
RIVASTIGMINE TARTRATE capsules USP, 4.5 mg are red cap and red body colored size ‘2’ capsules imprinted in black ink with ‘H’ on cap and ‘69’ on body, containing white to off-white granular powder. Bottles of 60 NDC 65862-650-60 Bottles of 500 NDC 65862-650-05 10 x 10 Unit-dose capsules NDC 65862-650-78
RIVASTIGMINE TARTRATE capsules USP, 6 mg are red cap and orange body colored size ‘2’ capsules imprinted in black ink with ‘H’ on cap and ‘70’ on body, containing white to off-white granular powder. Bottles of 60 NDC 65862-651-60 Bottles of 500 NDC 65862-651-05 10 x 10 Unit-dose capsules NDC 65862-651-78 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store in a tight container.
More pills like CAPSULE H 68